Coxsackievirus A6 Infection Causes Neurogenic Pathogenesis in a Neonatal Murine Model
暂无分享,去创建一个
Jichen Li | Tiantian Sun | Qiang Sun | Congcong Wang | Rui Wang | Ying Liu | Yong Zhang | Yang Song | Yanjun Zong | Xiaoliang Li
[1] N. Roberts,et al. Clinical manifestations of coxsackievirus A6: what a dermatologist needs to know , 2022, International journal of dermatology.
[2] Bo Zhang,et al. Transcriptome sequencing analysis of echovirus 30 infection reveals its potential pathogenesis , 2022, Frontiers in Microbiology.
[3] G. Duan,et al. A mouse-adapted CVA6 strain exhibits neurotropism and triggers systemic manifestations in a novel murine model , 2022, Emerging microbes & infections.
[4] Wenbo Xu,et al. Pathological Characteristics of Echovirus 30 Infection in a Mouse Model , 2022, Journal of virology.
[5] J. Juang,et al. Neurotropic EV71 causes encephalitis by engaging intracellular TLR9 to elicit neurotoxic IL12-p40-iNOS signaling , 2022, Cell Death & Disease.
[6] Wenbo Xu,et al. Pathological Features of Echovirus-11-Associated Brain Damage in Mice Based on RNA-Seq Analysis , 2021, Viruses.
[7] Huiqing Liu,et al. USP18 positively regulates innate antiviral immunity by promoting K63-linked polyubiquitination of MAVS , 2021, Nature Communications.
[8] Xiaomei Lu,et al. A 10-Day-Old Murine Model of Coxsackievirus A6 Infection for the Evaluation of Vaccines and Antiviral Drugs , 2021, Frontiers in Immunology.
[9] M. Kaul,et al. Innate Immune Sensing of Viruses and Its Consequences for the Central Nervous System , 2021, Viruses.
[10] S. Shen,et al. Efficacy of a coxsackievirus A6 vaccine candidate in an actively immunized mouse model , 2021, Emerging microbes & infections.
[11] Yunhui Zhang,et al. Comprehensive analysis of differential expression profiles via transcriptome sequencing in SH-SY5Y cells infected with CV-A16 , 2020, PloS one.
[12] M. Aepfelbacher,et al. Neuropathology of patients with COVID-19 in Germany: a post-mortem case series , 2020, The Lancet Neurology.
[13] Sheng Wei,et al. Risk factors for severe hand, foot, and mouth disease infected with Coxsackievirus A6: A hospital‐based case‐control study , 2020, Journal of medical virology.
[14] Wenbo Xu,et al. Genetic recombination in fast-spreading coxsackievirus A6 variants: a potential role in evolution and pathogenicity , 2020, Virus Evolution.
[15] Jie Dong,et al. Heightened Innate Immune Responses in the Respiratory Tract of COVID-19 Patients , 2020, Cell Host & Microbe.
[16] Yunhui Zhang,et al. Transcriptome sequencing analysis of SH-SY5Y cells infected with EV71 reveals the potential neuropathic mechanisms. , 2020, Virus research.
[17] Lisu Huang,et al. Neonatal hand, foot, and mouth disease due to coxsackievirus A6 in Shanghai , 2019, BMC Pediatrics.
[18] Q. Lu,et al. A review and meta‐analysis of the epidemiology and clinical presentation of coxsackievirus A6 causing hand‐foot‐mouth disease in China and global implications , 2019, Reviews in medical virology.
[19] Jianguo Wu,et al. EV71 infection induces neurodegeneration via activating TLR7 signaling and IL-6 production , 2019, PLoS pathogens.
[20] Zhen Zhu,et al. Surveillance, epidemiology, and pathogen spectrum of hand, foot, and mouth disease in mainland of China from 2008 to 2017 , 2019, Biosafety and Health.
[21] Yi Tan,et al. Six amino acids of VP1 switch along with pandemic of CV-A6-associated HFMD in Guangxi, southern China, 2010-2017. , 2019, The Journal of infection.
[22] J. Locasale,et al. The Nucleotide Sensor ZBP1 and Kinase RIPK3 Induce the Enzyme IRG1 to Promote an Antiviral Metabolic State in Neurons , 2019, Immunity.
[23] M. Luo,et al. Clinical features and phylogenetic analysis of severe hand-foot-and-mouth disease caused by Coxsackievirus A6. , 2019, Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases.
[24] G. Ebel,et al. An mRNA Vaccine Protects Mice against Multiple Tick-Transmitted Flavivirus Infections , 2018, Cell Reports.
[25] Wenyan Zhang,et al. Divergent Pathogenic Properties of Circulating Coxsackievirus A6 Associated with Emerging Hand, Foot, and Mouth Disease , 2018, Journal of Virology.
[26] G. Neale,et al. IRF1 Is a Transcriptional Regulator of ZBP1 Promoting NLRP3 Inflammasome Activation and Cell Death during Influenza Virus Infection , 2018, The Journal of Immunology.
[27] Elliot J. Lefkowitz,et al. Virus taxonomy: the database of the International Committee on Taxonomy of Viruses (ICTV) , 2017, Nucleic Acids Res..
[28] Juan Li,et al. A Neonatal Murine Model of Coxsackievirus A6 Infection for Evaluation of Antiviral and Vaccine Efficacy , 2017, Journal of Virology.
[29] Ting Zhao,et al. The Preferential Infection of Astrocytes by Enterovirus 71 Plays a Key Role in the Viral Neurogenic Pathogenesis , 2016, Frontiers in cellular and infection microbiology.
[30] C. Farina,et al. Astrocytes: Key Regulators of Neuroinflammation. , 2016, Trends in immunology.
[31] Kevin W. Kelley,et al. Astrocyte-encoded positional cues maintain sensorimotor circuit integrity , 2014, Nature.
[32] Hongling Zhao,et al. Neonatal rhesus monkey is a potential animal model for studying pathogenesis of EV71 infection. , 2011, Virology.
[33] N. Nagata,et al. Differential localization of neurons susceptible to enterovirus 71 and poliovirus type 1 in the central nervous system of cynomolgus monkeys after intravenous inoculation. , 2004, The Journal of general virology.
[34] Hour‐Young Chen,et al. Early and rapid detection of enterovirus 71 infection by an IgM-capture ELISA. , 2004, Journal of virological methods.
[35] N. Nagata,et al. Pyramidal and extrapyramidal involvement in experimental infection of cynomolgus monkeys with enterovirus 71 , 2002, Journal of medical virology.